Evidence map›Paper›PMID 19283913›Full record

ReviewCurrent opinion in infectious diseases2009

New diagnostic methods for tuberculosis.

Melissa R Nyendak, Deborah A Lewinsohn, David M Lewinsohn

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Pulmonary Tuberculosis Diagnosis: Where We Are?Tuberculosis and respiratory diseases · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melissa R NyendakDivision of Infectious Diseases, Oregon Health and Science University, Portland, OR 97239, USA.
Deborah A Lewinsohn
David M Lewinsohn
Oregon Health & Science University · USOffice of Infectious Diseases · US

Funding

Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Oregon Clinical and Translational Science InstituteKL2RR024141 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$3.6M
Tuberculosis Immunity in Young ChildrenR01AI054474 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DEBORAH A. · 2003 to 2006
$1.3M
NCRR NIH HHS 5 KL2 RR 024141-03NCRR NIH HHS KL2 RR024141NIAID NIH HHS N01 AI 400081NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI 054474NIAID NIH HHS R01 AI054474NIAID NIH HHS R01 AI 48090
6 · The paper itself

Abstract

purpose of reviewDuring the last decade, laboratory tests for the detection of Mycobacterium tuberculosis (Mtb) have improved dramatically. Improvements in the ability to detect latent infection with Mtb, disease associated with Mtb, and strains resistant to commonly used antibiotics are reviewed. RECENT

findingsAdvances in the detection of Mtb include light-emitting diode fluorescence microscopy, nucleic acid amplification of Mtb and drug-resistant strains, and more rapid liquid culture with adjunct drug susceptibility testing. In the detection of latent tuberculosis infection, interferon [gamma] release assays offer improved accuracy over the tuberculin skin test. SUMMARY: The past 10 years have seen the most rapid growth in new diagnostics for Mtb in over a century. Although these tests offer improvements in the ability to detect Mtb, drug-resistant isolates, and those with latent tuberculosis infection, these improvements are counter-balanced by the need to deploy these tests in areas where Mtb burden is highest.

Indexed as

HumansInterferon-gammaLeukocytes, MononuclearMycobacterium tuberculosisTuberculin TestTuberculosisInterferon-gamma

Identifiers

PMID19283913
PMCPMC3889480
OpenAlexW2005548728

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.